Get the Stockscreener App
1.60
2.44%
-0.04
After Hours:
1.60
Ispecimen Inc stock is traded at $1.60, with a volume of 62,896.
It is down -2.44% in the last 24 hours and down -20.40% over the past month.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
See More
Previous Close:
$1.64
Open:
$1.62
24h Volume:
62,896
Relative Volume:
0.27
Market Cap:
$4.03M
Revenue:
$1.03M
Net Income/Loss:
$-11.10M
P/E Ratio:
-0.0242
EPS:
-66.0832
Net Cash Flow:
$-8.21M
1W Performance:
-29.52%
1M Performance:
-20.40%
6M Performance:
-84.00%
1Y Performance:
-94.60%
1-Day Range:
$1.55
$1.65
1-Week Range:
$1.40
$1.9498
52-Week Range:
$1.40
$127.20
Ispecimen Inc Stock (ISPC) Company Profile
Name
Ispecimen Inc
Sector
Industry
Phone
781-301-6700
Address
8 CABOT ROAD, WOBURN
Compare ISPC vs TMO, DHR, NTRA, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISPC
Ispecimen Inc
|
1.60 | 5.72M | 1.03M | -11.10M | -8.21M | -66.08 |
TMO
Thermo Fisher Scientific Inc
|
630.70 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
215.68 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
338.70 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
157.69 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
262.38 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
Ispecimen Inc Stock (ISPC) Latest News
iSpecimen (ISPC) Earnings Snapshot: The Available Earnings Metric Delivers a Miss under the Current Snapshot; Post-Report: Shares Finish 4.62% Down in the Latest ReadingBalance Sheet Strength - vinanet.vn
iSpecimen completes cancer research project in three weeks - Investing.com
iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks - The Manila Times
iSpecimen completes cancer research project in three weeks By Investing.com - Investing.com UK
iSpecimen Delivers Hundreds of International Cancer Blood Specimens Within Three Weeks, Highlighting Biospecimen Network Capabilities - kalkine.ca
ISPC Stock Quote Price and Forecast - CNN
iSpecimen (ISPC) Quarter in Focus: EPS Does Not Reach the Reported Estimate for the Current Session - dars.gov.et
iSpecimen (ISPC) Close in Focus: Gains 8.84% to Reach $2.34; Price Context: the Supplied Trading Band Runs From $2.22 to $2.46 in the Available RecordLong Term Entry Picks - vinanet.vn
iSpecimen Inc. (ISPC) Pulls Back 2.81% to $2.25 as Traders Eye Key Support ZoneCall Dominated - vinanet.vn
iSpecimen Inc. (ISPC) Slips 2.81% as Shares Test Key Technical LevelsPrice Momentum Stocks - dars.gov.et
iSpecimen Flags Going Concern Doubt After Q2 Revenue Falls 79% - Minichart
iSpecimen Pays $2 Million for Three-Month Marketing Agreement - Minichart
Ispecimen Stock Price Forecast. Should You Buy ISPC? - StockInvest.us
iSpecimen Engages IR Agency for Investor Marketing - TipRanks
iSpecimen (ISPC) revenue drops to $308K as losses deepen and cash burns - Stock Titan
iSpecimen | 10-Q: Q2 2026 Earnings Report - Moomoo
ISpecimen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Form 8K iSpecimen Inc For: 11 August By Investing.com - Investing.com India
iSpecimen settles arbitration with WestPark Capital for $97,500, ends agreements - Investing.com South Africa
IspecimenEnters Settlement Agreement With Westpark Capital On August 6, 2026 - TradingView
iSpecimen Settles Arbitration and Terminates WestPark Agreements - TipRanks
E.F. Hutton & Co. Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen - The Manila Times
iSpecimen Completes $5 Million Public Offering - The Globe and Mail
E.F. Hutton serves as placement agent for iSpecimen $5M offering By Investing.com - Investing.com India
E.F. Hutton serves as agent for iSpecimen $5M offering By Investing.com - Investing.com UK
iSpecimen Inc. Prices $5 Million Public Offering of Common Stock and Pre-Funded Warrants to Fuel Growth and Innovation – Minichart - Minichart
iSpecimen Inc (ISPC) Stock News Today - TradingKey
iSpecimen Inc (ISPC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
E.F. Hutton serves as placement agent for iSpecimen $5M offering - Investing.com Nigeria
ISpecimen Closes $5 Million Public Offering of Common Stock, Warrants - marketscreener.com
iSpecimen Inc. Closes $5 Million Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded ... - Caledonian Record
E.F. Hutton serves as agent for iSpecimen $5M offering - Investing.com
E.F. Hutton & Co. Acts as Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen - The Manila Times
iSpecimen Inc. (ISPC) Edges Higher: Testing Key Resistance at $2.33Price Surge Stocks - dars.gov.et
iSpecimen prices $5M public offering at $1.30 per share By Investing.com - Investing.com India
iSpecimen prices $5M public offering at $1.30 per share - Investing.com
ISpecimen Inc. Announces Pricing of $5 Millio - Moomoo
iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants - Yahoo Finance
iSpecimen Inc. (ISPC) Falls 10.7% to $1.92 as Key Support Comes into FocusDealer Gamma - vinanet.vn
iSpecimen (ISPC) Breaks Out with +3.28% Surge Past $1.98 2026-08-02Fibonacci Retracement - dars.gov.et
iSpecimen (ISPC) Rises 3.28% to $1.89, Testing Key Resistance at $1.98Bullish Sentiment - vinanet.vn
iSpecimen Inc. SEC Filing (Jul 31, 2026) - Stock Titan
iSpecimen Company Profile & Introduction - Moomoo
iSpecimen Inc. Revenue Breakdown – NASDAQ:ISPC - TradingView
iSpecimen (ISPC) Q3 2024 Earnings: EPS Misses by Over 980% Amid No Reported RevenueEarnings Beat Streak - dars.gov.et
ISPC Q3 2024 Earnings: EPS Misses by Wide Margin as Company Reports No RevenueEarnings Power Value - vinanet.vn
iSpecimen Inc (ISPC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ISPC|iSpecimen Inc|Price:2.280|Chg%:+0.040 - tradingkey.com
iSpecimen Inc (ISPC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
iSpecimen Inc (ISPC) Cash Flow - TradingKey
Ispecimen Inc Stock (ISPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.24%
1.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):